Actinium Pharmaceuticals to Present at BIO CEO & Investor Conference
Feb 09, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...
Actinium Pharmaceuticals to Present at BIO CEO & Investor Conference
Feb 09, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...
Merus to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Feb 09, 2017 12:01 pm UTC| Business
UTRECHT, The Netherlands, Feb. 09, 2017 -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, Ph.D., Chief...
Merus to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Feb 09, 2017 12:01 pm UTC| Business
UTRECHT, The Netherlands, Feb. 09, 2017 -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, Ph.D., Chief...
Broadwind To Announce Q4 and Full-Year 2016 Results on February 23
Feb 09, 2017 12:01 pm UTC| Business
CICERO, Ill. , Feb. 09, 2017 -- Broadwind Energy, Inc. (NASDAQ:BWEN) will announce fourth quarter and full-year 2016 results on Thursday, February 23, 2017 before market open. An investor conference call will follow at...
Broadwind To Announce Q4 and Full-Year 2016 Results on February 23
Feb 09, 2017 12:01 pm UTC| Business
CICERO, Ill. , Feb. 09, 2017 -- Broadwind Energy, Inc. (NASDAQ:BWEN) will announce fourth quarter and full-year 2016 results on Thursday, February 23, 2017 before market open. An investor conference call will follow at...
Feb 09, 2017 12:00 pm UTC| Business
YAVNE, Israel , Feb. 09, 2017 -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces positive...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight